-
Consumer Insights
NewSpain Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
This report provides detailed consumer insights into Spanish apparel market. It centers on consumer sentiment, categories purchased, channel usage, motivations for purchasing, purchase frequency and the most popular global brands. Spain’s inflation rate is softening, slowing to 3.8% in December 2023 from 8.3% in 2022, driving less than half of consumers to expect the economy to get worse in the next six months. In 2023, 81.4% of apparel shoppers bought items instore, while 61.1% purchased online, as consumers favoured being...
-
Consumer Insights
NewItaly Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
This report provides detailed consumer insights into Italy's apparel market. It centers on consumer sentiment, categories purchased, channel usage, motivations for purchasing, purchase frequency and the most popular global brands. Many Italian consumers expect financial hardships to continue, with 49.0% and 30.9% anticipating that the economy and personal finances, respectively, will worsen over the next six months. As a result, 57.3% intend to reduce their retail expenditure, mainly by doing more price comparisons and shifting to cheaper brands. More Italian...
-
Consumer Insights
NewFrance Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
France Apparel Consumer Insights Report Overview More than 35% of French consumers plan to cut back on their clothing & accessories spending this year. Easing inflation rates has also failed to reassure French consumers about the state of the economy over the next six months. Economic pressures are driving many consumers to switch to cheaper brand alternatives. The ‘France Apparel Consumer Insights Report’ provides detailed insights into consumer sentiment among apparel shoppers in France. This report offers a detailed analysis...
-
Consumer Insights
NewGermany Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
Germany Apparel Consumer Insights Report Overview According to GlobalData’s Germany Consumer Survey, conducted in December 2023, it was identified that many German consumers continue to suffer from the impact of high inflation, which is expected to worsen in the coming months. As a result, consumers were spending less on retail products, with many switching to cheaper brands and doing more price comparisons online. Major German retailers such as Zalando and Otto were offering myriad options and easy price comparisons to...
-
Consumer Insights
United Kingdom (UK) Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
UK Apparel Consumer Insights Report Overview Womenswear was the most popular category, bought by more than 61% of the UK consumers that purchased clothing overall in 2023. The growth of the womenswear category is attributed to women’s stronger desire to buy into trends and refresh their wardrobes, whereas men generally prefer more classic styles that need replacing less often. Many UK consumers have purchased apparel secondhand over the past 12 months, due to women shoppers as there are more products...
-
Sector Analysis
NewSix Nations (Rugby Championship), 2024 – Event Analysis
An analysis of the recent 2024 Six Nations, including a look at its sponsorship portfolio, broadcasters, attendance and ticketing. The Six Nations 2024 generated an estimated $177.68 million in media revenue from competing nations. In the United Kingdom, ITV have the broadcasting rights for all the home matches for England. Ireland, France, and Italy, while the BBC showed the coverage of games in Cardiff at the Principality Stadium and Edinburgh at Murrayfield for Wales and Scotland, respectively. England's defeat to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Daratumumab + Hyaluronidase (human Recombinant)) in Peripheral Neuropathy (Sensory Neuropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Daratumumab + Hyaluronidase (human Recombinant)) in Peripheral Neuropathy (Sensory Neuropathy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Daratumumab + Hyaluronidase (human Recombinant)) in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Daratumumab + Hyaluronidase (human Recombinant)) in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Daratumumab + Hyaluronidase (human Recombinant)) in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Daratumumab + Hyaluronidase (human Recombinant)) in Alzheimer's Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Daratumumab + Hyaluronidase (human Recombinant)) in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Daratumumab + Hyaluronidase (human Recombinant)) in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Daratumumab +...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Upadacitinib ER in Alopecia Areata report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Alopecia Areata Drug Details: Upadacitinib (Rinvoq, Rim-Voq)...